(Q80442663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Massimo Accorinti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maria Pia Pirraglia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maria Pia Paroli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Roberta Priori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Fabrizio Conti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Paola Pivetti-Pezzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

Japanese Journal of Ophthalmology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

191-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554481%20AND%20SRC:MED&resulttype=core&format=json

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

31 December 2019

cites work

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

1 reference

12 December 2020

Anti-TNF-alpha therapy for sight threatening uveitis

1 reference

12 December 2020

Treatment with infliximab for a child with Behçet's disease

1 reference

12 December 2020

Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation

1 reference

12 December 2020

Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27.

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

12 December 2020

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

1 reference

12 December 2020

Tuberculosis and treatment with infliximab

1 reference

12 December 2020

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

12 December 2020

Behçet's disease: a new target for anti-tumour necrosis factor treatment

1 reference

12 December 2020

Infliximab in the treatment of refractory posterior uveitis

1 reference

12 December 2020

Safety of tumour necrosis factor-alpha antagonists

1 reference

12 December 2020

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

1 reference

12 December 2020

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

1 reference

12 December 2020

Interferon alpha for ocular Behçet's disease

1 reference

12 December 2020

Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Immunopathology of the noninfectious posterior and intermediate uveitides

1 reference

12 December 2020

Prognosis in Behcet's disease

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).

1 reference

12 December 2020

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

1 reference

12 December 2020

Effect of infliximab on threatening panuveitis in Behçet's disease

1 reference

12 December 2020

[Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report]

1 reference

12 December 2020

Azathioprine in Behcet's syndrome: effects on long-term prognosis

1 reference

12 December 2020

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease

1 reference

12 December 2020